UK company uses the world's smallest scaffolding to build new livers

Ann Kramer
Ann Kramer, CEO, The Electrospinning Company
(Credit: The Electrospinning Company)

A UK company is using technology originally designed for use in Space to assist in a ground-breaking project that aims to improve the treatment of liver-associated diseases. Ultimately it could develop a new generation of liver replacements, using fibres a hundred times thinner than a human hair.

Waiting for a replacement organ that never comes is the heart breaking truth for 14% of patients requiring a liver transplant. The demand for replacement livers has always far outweighed supply, with over 10,000 people waiting for a liver transplant in the EU alone. Many patients die, or become too sick to undergo surgery during the wait.

Now, the Electrospinning Company (TECL), a spin out from the Science and Technology Facilities Council (STFC), is taking part in Re-Liver, a ground-breaking EU funded project in regenerative medicine, to improve the treatment of liver-associated diseases and, ultimately, develop a new generation of liver replacements.

electrospun scaffold
An electrospun scaffold using fibres a hundred times thinner than a human hair.
(Credit: The Electrospinning Company)

With industrial and academic partners in Germany and Italy, alongside the University of Manchester, the project is developing artificially grown, mini liver organs, known as organoids. These organoids consist of cells that provide liver cell functions, which could be used to treat liver-associated diseases such as haemophilia.

For its part in the project, TECL is combining space technology developed at STFC with a process known as electrospinning, in which an electrical charge is used to produce fibres that are a hundred times thinner than a human hair. These fibres are electrospun into microscopic 3D scaffolds, much smaller than the eye can see. Composed from synthetic, medical grade polymers which mimic the cellular behaviour of real human tissues, these scaffolds have been approved by the US Food and Drug Administration (FDA).

Dr Kate Ronayne, Head of Innovation at STFC, said: “TECL’s microscopic scaffolds provide the ideal environment to support the growth of functioning 3D liver cells. Its role in the project could have a huge impact on the future of regenerative medicine. This is a fantastic example of how world class science, teamed with STFC’s business management and innovation support, can help small companies, with brilliant ideas, to address the really significant challenges facing our society today.

This three year project will confirm proof of principle for this technology, and investigate all safety aspects, to allow clinical trials to begin. The long-term goal is the development of artificial organoids that could be transplanted into the body to supplement, or even eventually replace, lost liver activity.

Ann Kramer, CEO of TECL, said: “We are thrilled to be part of this project, which has the real potential to impact both regenerative medicine and liver toxicity screening in the near future. Our participation has been helped greatly by the innovation management and support of STFC.”

END

Further information

The Re-Liver project is funded by the EU Seventh Framework Programme (FP7/2007-2013). Project 304961.

Images available:

  • An electrospun scaffold
  • Ann Kramer, CEO at The Electrospinning Company

Contact:

Wendy Ellison
STFC Press Officer
Tel: 01925 603232
Mob: 07919 548012
Email: wendy.ellison@stfc.ac.uk

About The Electrospinning Company (TECL)

The Electrospinning Company was established in 2010 to develop commercial products from IP developed at STFC’s Rutherford Appleton Laboratory. Since then the company has gone from strength to strength while enjoying the support of STFC in the form of both the Innovations Technology Access Centre (I-TAC) and ESA Business Incubation Centre Harwell.

The company graduated from ESA BIC Harwell in June 2013, but remains located on the Harwell Campus campus as an I-TAC tenant, where they rent labs, office space and high specification equipment for their research and development.

The Science and Technology Facilities Council (STFC) is keeping the UK at the forefront of international science and tackling some of the most significant challenges facing society such as meeting our future energy needs, monitoring and understanding climate change, and ensuring global security. STFC is one of seven publicly-funded research councils. It is an independent, non-departmental public body of the Department for Business, Innovation and Skills (BIS).

Follow us on Twitter at @STFC_Matters.

www.stfc.ac.uk.

Science and Technology Facilities Council Switchboard: 01793 442000